SECOND
PART- TRENDS AND DEVELOPMENT OF SPECIFIC TELEHEALTH SECTORS
SECOND PART- TRENDS AND DEVELOPMENT OF SPECIFIC TELEHEALTH SECTORS
Sectoral legal advice for clients from the telemedicine sector requires from lawyers to constantly monitor the market in this sector and constantly expand their knowledge of market needs. It is the duty of every lawyer of KIEŁTYKA GŁADKOWSKI to be up-to-date with the sector of economic activity on which they provide legal services. Proper legal advice requires from lawyers to know the market practice of a given sector, and above all, knowledge of complex IT terminology and the basics of the pharmaceutical market.
I
Telehealth trends’ perspectives
On
the Telehealth Investment Trends we can have a look from different
perspectives.
One
of these perspectives is a funding perspective. In the 2nd quarter
of 2021 we can notice a funding record broken for the 4th quarter in
a row (from the 3rd quarter of 2020). The deal count amounted 163
deals and the funding amounted 5,038 (in millions of dollars).
The
continental differences. It is explicitly noticeable that European investment
nearly quintupled QoQ to reach a record high of $915M. Asian investments almost
halved, north American investment slightly increased but European made an incredible
investment growth which might be a long-perspective tendency (especially
regarding the COVID-19 pandemic and Europe’s ageing an increasingly digitalized
society). Among these reasons and investment tendencies the polish executive
in the abovementioned ordinance included the procedures to impart instructions
about e- medical prescription realization, additional treatment, tests
realization (including laboratory tests) and possibility to sign up an Online
Patient Account[1].
These procedures and medical services requirements can be (and in deed will be
for sure) unquestionably helpful for older people who are yet to learn with
increasingly used IT systems.
The
differences between early-, mid- and late- stage deal percentage. It is worthy
to notice that in the 2021 early-stage deal share tracked at a historical low
but at the same time the late-stage share at its high level (12% in comparison
to previous 8%). This may reflect the increasing sophistication and maturity of
the telehealth industry and of course the maturity and investment development
and advancement of telehealth entities.
MEDICINE
TELE-SECTORS- TELE-TECHNOLOGIES AND NEW OPPORTUNITIES FOR PATIENTS
MEDICINE TELE-SECTORS- TELE-TECHNOLOGIES AND NEW OPPORTUNITIES FOR PATIENTS
Nowadays
an issue like telehealth or telemedicine is not something abnormal,
extraordinary or an extravagancy for richer part of the society. Moreover under
circumstances of COVID-19 pandemic the telehealth sector became more known
(thus in many countries telemedicine is a well-known medicine and services sector) and, what is more
relevant, it became one of the most (or even the most) crucial and indispensable
way to communicate with the doctor and to take care of yourself.
Fast,
easy to operate, straightforward and accessible for every internet and phone
users telehealth expanded into our life and our health-life. It is a undoubtful
fact that it is one of the most rapidly, dynamically, successfully branch of
economy, especially in the life sciences sector. The 4th economic
revolution we are experiencing and participating (consciously or unconsciously)
impressed us on the fact that an iphone just a smartphone has become the
command and management centre of our lives. Therefore we also use our phones (electronic
devices in general) to control, observe and manage our health- life or even
health life of our children, relatives and pets. Companies have long noticed
this medical-technological trend, but now (also due to the global situation) it
has significantly accelerated.
In
support of this thesis, we want to submit you a new report (CB Insights report)
about the state of telehealth sector and polish, detailed regulation (The
Minister of Health ordinance from 12th August, 2020) about the
tele-med-guidance rules.
FIRST
PART- TELEHEALTH MARKET RECOVERY
I
The
CB INSIGHTS published a report- State Of Telehealth Q2’21 Report: Investment
& Sector Trends To Watch which in a very adequate, professional and analytical way pointes the
main global trends in a telehealth economic sector out and uses the examples of
the biggest transactions, M&A with extensive use of statistical data,
diagrams and schemes.
On the 3th July 2021 the amendments of the Rules of Polish Civil Procedure and other statutory laws (especially the statutory law about solutions related to preventing, counteracting and combating COVID- 19) have entered into force.
The Act of the Council of Ministers’ initiative provides for a number of changes in the Polish civil procedure, including:
more
online hearings,
participation
of witnesses in remote hearings,
examination
of the case by a single-judge panel,
new
procedure for the service of judicial documents,
PLAN, CAPTURE AND SET THE INFRASTRUCTURE FOR DATA SHARING ACROSS THE VALUE CHAIN, TO OPTIMIZE COMMERCIAL STRATEGY.
On July 29, 2021 KG Legal Kiełtyka Gładkowski will take part in webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ organized by Reuters as part of the activities of Pharma Boardroom (the global platform for C -level healthcare executives) in partnership with Sales force. This online-conference will focus on the life-changing cell and gene therapies and related with it value chains of these therapies and data transfer between the stakeholders.
The bankruptcy cases are regulated in Poland majorly by the Insolvency Act of 2003 (in Polish: Ustawa z dnia 28 lutego 2003 r. Prawo upadłościowe (t.j. Dz. U. z 2020 r. poz. 1228 z późn. zm.)) (later: ‘Insolvency Act of 2003’). Yet it is not the only applicable regulation. In cases of cross-border bankruptcy proceedings or cases where a Polish citizen is adjudged bankrupt in the territory of the Member State of the European Union or Ireland, the bankruptcy proceedings are regulated by the Regulation (EU) 2015/848 of the European Parliament and of the Council of 20 May 2015 on insolvency proceedings (OJ L 141, 5.6.2015, p. 19-72) (later: ‘Regulation 2015/848’).
